Impact of HIV infection on meningitis in Harare, Zimbabwe: A prospective study of 406 predominantly adult patients

AIDS

Volumn 14, Issue 10, 2000, Pages 1401-1407

  Hakim, James G ^a   Gangaidzo, Innocent T ^b   Heyderman, Robert S ^b   Mielke, Jens ^b   Mushangi, Ebbah ^b   Taziwa, Albert ^b   Robertson, Valerie J ^b   Musvaire, Praise ^b   Mason, Peter R ^b  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b NONE

Author keywords

Aetiology; Cryptococcal meningitis; HIV; Meningitis; Pyogenic meningitis; Tuberculous meningitis; Zimbabwe

Indexed keywords

ANTIBIOTIC AGENT; PENICILLIN G;

ADOLESCENT; ADULT; ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CLINICAL TRIAL; FEMALE; FUNGAL MENINGITIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENINGITIS; MONONUCLEAR CELL; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; TUBERCULOUS MENINGITIS; UNIVERSITY HOSPITAL; ZIMBABWE;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MENINGITIS; MENINGITIS, CRYPTOCOCCAL; MIDDLE AGED; PROSPECTIVE STUDIES; TUBERCULOSIS, MENINGEAL; ZIMBABWE;

EID: 0033925332     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200007070-00013     Document Type: Article

References (27)

1. 1. Marshall DW, Brey RL, Cahill WT, et al. Spectrum of cerebrospinal fluid findings in various stages of human immunodeficiency virus infection. Arch Neurol 1988, 45:954-958.
2. 2. McArthur JC, Sipos E, Cornblath DR, et al. Identification of mononuclear cells in CSF of patients with HIV infection. Neurology 1989, 39:66-70.
3. 3. Grant AD, Djomand G, Smets P, et al. Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Cote d'lvoire. AIDS 1997, 11:1357-1364.
4. 4. Jennett B, Teasdale G. Aspects of coma after severe head injury. Lancet 1977, i:878-881.
5. 5. Ministry of Health and Child Welfare. Essential Drugs List for Zimbabwe. Harare: Ministry of Health; 1994.
6. 6. Heyderman RS, Gangaidzo IT, Hakim JG, et al. Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis 1998, 26:284-289.
7. 7. Manson DY. Immunocytochemical labelling of monoclonal antibodies by the APAAP immunoalkaline phosphate technique. In Techniques in Immunocytochemistry. Edited by Bullock GR, Pertrusz P. New York: Academic Press; 1988:25-42.
8. 8. UNAIDS. AIDS Epidemic Update. UNAIDS, December 1998.
9. 9. Bergemann A, Karstaedt AS. The spectrum of meningitis in a population with high prevalence of HIV disease. Q J Med 1996, 89:499-504.
10. 10. Pallangyo K, Hakanson A, Lema L, et al. High HIV seroprevalence and increased HIV-associated mortality among hospitalized patients with deep bacterial infections in Dar-es-Salaam, Tanzania. AIDS 1992, 6:971-976.
11. 11. Kovas JA, Kovas AA, Polis M, et al. Cryptococcus in the acquired immunodeficiency syndrome. Ann Intern Med 1985, 103: 533-538.
12. 12. Maher D, Mwandumba H. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi. J Infect 1994, 28:59-64.
13. 13. Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993, 17:837-842.
14. 14. Taelman H, Clernix J, Kagame A, et al. Cryptococcosis - another growing burden for Central Africa. Lancet 1991, 338:761.
15. 15. Harries AD. Tuberculosis and human immunodeficiency virus infection in developing countries. Lancet 1990, 335:387-390.
16. 16. De Cock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa [review]. J Am Med Assoc 1992, 268:1581-1587.
17. 17. Elliott EM, Luo N, Tembo C, et al. Impact of HIV on tuberculosis in Zambia: a cross sectional study. Br Med J 1990, 301: 412-415.
18. 18. Hopewell PC. Impact of HIV infection on the epidemiology, clinical features, management and control of tuberculosis. Clin Infect Dis 1992, 15:540-547.
19. 19. McLeod DT, Neill P, Robertson VJ, et al. Pulmonary diseases in patients infected with the human immunodeficiency virus in Zimbabwe, Central Africa. Trans Roy Soc Trop Med Hyg 1989, 83:694-697.
20. 20. Butungwanayo J, Taelman H, Bogaerts J, et al. Pulmonary cryptococcosis associated with HIV-1 infection in Rwanda: a retrospective study of 37 cases. AIDS 1994, 8:1271-1276.
21. 21. Driver JA, Saunders CA, Heinze-Lacey B, Sugar AM. Cryptococcal pneumonia in AIDS: is cryptococcal meningitis preceded by clinically recognizable pneumonia? J AIDS 1995, 9:168-171.
22. 22. Gilks CF, Brindle RJ, Otieno LS, et al. Life threatening bacteraemia in HIV-1 seropositive adults admitted to hospital in Nairobi, Kenya. Lancet 1990, 336:545-549.
23. 23. Heyderman RS, Gangaidzo IT, Hakim JG, et al. Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe [letter]. Clin Infect Dis 1998, 27:84-85.
24. 24. Zuger A, Lourie E, Holtzman R, Sunberkoff MS, Rahal JJ. Cryptococcal disease in patients with the acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann Intern Med 1986, 104:234-240.
25. 25. Pokert MT, Sotir M, Parratt-Moore P, Blumberg HM. Tuberculous meningitis at a large inner-city medical centre. Am J Med Sci 1997, 313:325-331.
26. 26. Yechoor VK, Shandera WX, Rodriguez P, Cate TR. Tuberculous meningitis among adults with and without HIV infection. Arch Intern Med 1996, 156:1710-1716.
27. 27. Van der Horst CM, Saag MS, Cloud GA, et al., and the National Institute of allergy and infectious diseases mycosis study group and AIDS clinical trials group. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. N Engl Med 1997, 337:15-21.